Related Party Transactions and Outside Related Director Information

Barrier Therapeutics, Inc. (BTRX)

4/27/2006 Proxy Information

In July 2004, we entered into an agreement with Janssen Pharmaceutica, NV under which we committed to purchase 1,000,000 of inventory within the two-year period ending July 2008. We recorded approximately $57,000 in 2005 related to this agreement.

We expensed approximately $14,000, $21,000 and $1,607,000 for the purchase of raw materials and clinical supplies from a Janssen during 2005, 2004 and 2003, respectively.